Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BPH ENERGY LTD Proxy Solicitation & Information Statement 2007

Sep 10, 2007

64555_rns_2007-09-10_18f1ff46-6d38-49ea-904e-fb7220094487.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

==> picture [134 x 60] intentionally omitted <==

11[th] September 2007

Companies Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Dear Sir/Madam,

RE: BIOPHARMICA LIMITED NOTICE OF MEETING

AMENDED INDICATIVE TIMETABLE TO CORRECT TYPOGRAPHICAL ERROR

IN SPECIE DISTRIBUTION OF CORTICAL DYNAMICS SHARES TO BIOPHARMICA LIMITED SHAREHOLDERS

EVENT DATE
BioPharmica Limited announces the reorganisation and sends out this Notice of
Meeting
31 August 2007
General Meeting of BioPharmica Limited shareholders 27 September 2007
BioPharmica Limited advises ASX that shareholder approval for the capital
reduction has been obtained
28 September 2007
Trading in BioPharmica shares starts on an “ex return of capital basis” 2 October 2007
Record Date 8 October 2007
Anticipated Despatch Date – Cortical Dynamics Shares to BioPharmica Limited 9 October 2007

Amendment Note: Please note that the original ASX announcement of the Notice of Meeting released on 30 August 2007 contained an error at clause 1.5(h). The term “twelve months” has been amended to “six months” and the correct text was distributed to shareholders in the Notice of Meeting sent out after the ASX release.

Yours Sincerely

==> picture [120 x 43] intentionally omitted <==

David Breeze Managing Director

BioPharmica Limited

ACN 95 912 002 PO Box 317, North Perth 6906, Western Australia 14 View Street, North Perth, Western Australia 6006 [email protected] www.biopharmica.com.au

T: +61 8 9328 8366 F: +61 8 9328 8733